Results 21 to 30 of about 45,109 (224)

Facile Synthesis of Propranolol and Novel Derivatives

open access: yesJournal of Chemistry, 2020
Propranolol is one of the first medications of the beta-blocker used for antihypertensive drugs. This study reports the facile route for the synthesis of propranolol and its novel derivatives.
Vy Anh Tran   +9 more
doaj   +1 more source

The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against Pseudomonas aeruginosa and Serratia marcescens

open access: yesBiomedicines, 2023
The development of bacterial resistance is an increasing global concern that requires discovering new antibacterial agents and strategies. Bacterial quorum sensing (QS) systems play important roles in controlling bacterial virulence, and their targeting ...
Hadil Faris Alotaibi   +7 more
doaj   +1 more source

The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study.

open access: yesPLoS ONE, 2019
BackgroundBeta-blockers can reduce recurrence, metastasis, and mortality in various cancers. In this study, we investigated the effect of propranolol, a non-selective beta-blocker on overall survival (OS) in unresectable/metastatic hepatocellular ...
Ping-Ying Chang   +7 more
doaj   +1 more source

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy

open access: yesScientific Reports, 2022
Osteosarcoma is still associated with limited response to standard-of-care therapy and alarmingly elevated mortality rates, especially in low- and middle-income countries.
Luisina M. Solernó   +7 more
doaj   +1 more source

Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study

open access: yesFrontiers in Pediatrics, 2019
Background: Recent explorative studies suggest that propranolol reduces retinopathy of prematurity (ROP) progression, but the short-term effects of propranolol treatment at 1 year of corrected age have not been extensively evaluated.Methods: A multi ...
Luca Filippi   +15 more
doaj   +1 more source

Efficient Propranolol Delivery Enabled by Manganese-Based Bioactive Metal-Organic Frameworks With High Loading Capacity. [PDF]

open access: yesChemistryOpen
A green and efficient method has been developed for propranolol delivery utilizing manganese‐based bioactive MOFs as biocompatible drug carriers. Mn‐based bioactive MOFs with a high aspect ratio are synthesized and characterized for size, morphology, stability, elemental composition, crystallinity, functionality, charge character, and biocompatibility [
Borhanipasvisheh H   +2 more
europepmc   +2 more sources

Efficacy and safety assessment of propranolol tablets vs. oral solution for infantile hemangioma: a retrospective study in China

open access: yesFrontiers in Pediatrics
BackgroundPropranolol for infantile hemangiomas (IHs) is effective and relatively safe. However, propranolol has different formulations and there is no consensus on the optimal formulation for IHs.
Wenting Chen   +8 more
doaj   +1 more source

Propranolol in hypertension [PDF]

open access: yesPostgraduate Medical Journal, 1968
Summary Twenty-four hypertensive patients, eleven of whom had angina pectoris as well, have been treated with propranolol in doses up to 400 mg daily. The thirteen patients without angina received methyldopa 2 g daily in addition to propranolol. A significant reduction of systolic and diastolic blood pressure was found in both groups.
S N, Tewari, R H, Grant
openaire   +2 more sources

Involvement of propranolol in suicides: cross-sectional study using coroner-reported data

open access: yesBJPsych Open
Background Propranolol is a beta-blocker medication indicated mostly for heart rhythm conditions and for physical symptoms of anxiety. Prescriptions for propranolol in the UK have increased since 2008.
Hayley C. Gorton   +4 more
doaj   +1 more source

Propranolol: A 50-year historical perspective

open access: yesAnnals of Indian Academy of Neurology, 2019
Propranolol is a beta-adrenergic receptor antagonist that was developed by the British scientist Sir James Black primarily for the treatment of angina pectoris, more than 50 years ago.
A V Srinivasan
doaj   +1 more source

Home - About - Disclaimer - Privacy